Top Cancer Researcher Fails To Disclose Corporate Financial Ties In Major Research Journals

The New York Times/ProPublica: Top Cancer Researcher Fails To Disclose Corporate Financial Ties In Major Research Journals

One of the world’s top breast cancer doctors failed to disclose millions of dollars in payments from drug and health care companies in recent years, omitting his financial ties from dozens of research articles in prestigious publications like The New England Journal of Medicine and The Lancet. The researcher, Dr. José Baselga, a towering figure in the cancer world, is the chief medical officer at Memorial Sloan Kettering Cancer Center in New York. He has held board memberships or advisory roles with Roche and Bristol-Myers Squibb, among other corporations, has had a stake in start-ups testing cancer therapies, and played a key role in the development of breakthrough drugs that have revolutionized treatments for breast cancer. (Ornstein and Thomas, 9/8)

Source : https://khn.org/morning-breakout/towering-figure-in-cancer-research-world-failed-to-disclose-financial-ties-to-drug-health-care-companies/

Towering Figure In Cancer Research World Failed To Disclose Financial Ties To Drug, Health Care Companies
Memorial Sloan Kettering’s Season of Turmoil
Prominent Doctors Aren't Disclosing Their Industry Ties in Medical Journal Studies. And Journals Are Doing Little to Enforce Their Rules
Resignation by Memorial Sloan Kettering’s Baselga should start bigger COI conversation, expert says
Director's Message: Conflict of Interest
Paul D Thacker: Time to act on industry influence over medicine and lay zombie arguments to rest
Do mobile phones cause cancer?
Journal flags papers, saying authors didn’t adequately disclose ties to Monsanto
Exclusive Investigative Report: Harvard’s Pediatric Nutrition Star Comes Under Scrutiny for Conflicts of Interest
Cancer Doctor Resigns From Sloan Kettering Over Financial Disclosure Controversy